Stem cells engineered with lentivirus expressing human fix for the treatment of hemophilia B

dc.contributor.author	Dodd, M.
dc.contributor.author	Markar, A.
dc.contributor.author	Marquez-Curtis, L.
dc.contributor.author	Wen, J.
dc.contributor.author	Janowska-Wieczorek, A.
dc.contributor.author	Hortelano, G.
dc.date.accessioned	2015-10-29T06:10:07Z
dc.date.available	2015-10-29T06:10:07Z
dc.date.issued	2013
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/573
dc.description.abstract	The aim of this study was to investigate an alternative treatment combining cellular and biomaterial therapy. Human mesenchymal stem cells (hMSC) have increasingly been investigated for cellular therapies due to their immunomodulatory properties and differentiation potential [2]. Enclosure of cells in alginate microcapsules offers immunoprotection to the cells and the added benefit of potential retrievability, enhancing the strategy’s safety.	ru_RU
dc.language.iso	en	ru_RU
dc.publisher	Nazarbayev University	ru_RU
dc.subject	first research week	ru_RU
dc.subject	Hemophilia B	ru_RU
dc.subject	stem cells	ru_RU
dc.title	Stem cells engineered with lentivirus expressing human fix for the treatment of hemophilia B	ru_RU
dc.type	Abstract	ru_RU